Elevated expression of serum soluble ST2 in clinical relapse after stopping long-term Nucleos(t)ide analogue therapy for chronic hepatitis B

Elevated expression of serum soluble ST2 in clinical relapse after stopping long-term Nucleos(t)ide analogue therapy for chronic hepatitis B

Abstract Background The virological or clinical relapse is common in chronic hepatitis B (CHB) patients after stopping long-term nucleos(t)ide analogue (NA) therapy. Soluble growth stimulation expressed gene 2 (sST2), one of the Toll-like/interleukin-1 receptor members, is involved in a variety of i...

Full description

Bibliographic Details
Main Authors: Linqing Xie, Guichan Liao, Hongjie Chen, Muye Xia, Xuan Huang, Rong Fan, Jie Peng, Xiaoyong Zhang, Hongyan Liu
Format: Article
Language:English
Published: BMC 2019-07-01
Series:BMC Infectious Diseases
Subjects:
Chronic hepatitis B
Nucleos(t)ide analogue therapy
Treatment cessation
Clinical relapse
Serum soluble ST2
Online Access:http://link.springer.com/article/10.1186/s12879-019-4261-3

Internet

http://link.springer.com/article/10.1186/s12879-019-4261-3

Similar Items